면책 고지: 이 사이트는 FDA, ClinicalTrials.gov, PubMed, SEC EDGAR 등 공식 공개 데이터를 일반 참고용으로 집계하며, 의학적 조언, 진단, 치료 권고 또는 투자 조언이 아닙니다.

PubMed

Clinical Evidence to Support US Food and Drug Administration Review of New Medical Technology in Pulmonary, Sleep, and Critical Care Medicine Between 2014 and 2024: A Scoping Review to Support Adoption in Practice.

PMID: 41429289 ·

J, a, c, k, , T, , G, a, r, d, n, e, r, ;, , J, o, n, a, t, h, a, n, , A, , B, u, s, a, m, ;, , E, r, i, c, , D, , S, h, a, h

학술지Chest
연도
PMID41429289

초록

Chest medicine relies extensively on medical devices that comprise medical technology, artificial intelligence, software applications, and digital health; however, a comprehensive assessment of the evidence supporting US Food and Drug Administration (FDA) approval/clearance of these devices is lacking. What are the trends and evidence related to new medical devices across chest medicine? We performed a scoping review according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.

↑